Reply to: "Comment on "Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort"".

ABSTRACT:

SUBMITTER: Lee J 

PROVIDER: S-EPMC11999278 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature